Literature DB >> 12203165

Bartonella quintana Bacteremia among Homeless People.

C Foucault1, K Barrau, P Brouqui, D Raoult.   

Abstract

Bartonella quintana infections have recently reemerged, predominantly among the homeless populations in cities in both Europe and the United States. B. quintana can cause trench fever, endocarditis, and chronic bacteremia; the human body louse is the only known vector. Homeless people who presented to the emergency departments of University Hospital in Marseilles, France, were studied, as were those who had been admitted to other medical facilities in the city since 1 January 1997. Samples of blood and body lice were collected for culture for B. quintana and for serological testing. Bartonella bacteremia was associated with sweats, evidence of louse infestation, serological tests that were positive for B. quintana, and high titers of B. quintana antibody. Bacteremia was also associated with being homeless for <3 years. Asymptomatic, prolonged bacteremia (duration, up to 78 weeks) and intermittent bacteremia were found to occur. Data obtained regarding antibiotic regimens showed that treatment with gentamicin and doxycycline was effective in preventing relapses of bacteremia.

Entities:  

Mesh:

Year:  2002        PMID: 12203165     DOI: 10.1086/342065

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  27 in total

Review 1.  Recommendations for treatment of human infections caused by Bartonella species.

Authors:  J M Rolain; P Brouqui; J E Koehler; C Maguina; M J Dolan; D Raoult
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

2.  Molecular detection of Bartonella quintana DNA in the dental pulp of a homeless patient.

Authors:  G Aboudharam; P-E Fournier; M Drancourt; D Raoult; C Foucault; P Brouqui
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-12       Impact factor: 3.267

3.  Analysis of the first Australian strains of Bartonella quintana reveals unique genotypes.

Authors:  Mark W Woolley; David L Gordon; Bruce L Wetherall
Journal:  J Clin Microbiol       Date:  2007-04-11       Impact factor: 5.948

4.  Isolation and characterization of Bartonella quintana from the parotid gland of an immunocompetent man.

Authors:  Giustina Vitale; Salvatore Incandela; Cinzia Incandela; Anna Micalizzi; Pasquale Mansueto
Journal:  J Clin Microbiol       Date:  2009-01-07       Impact factor: 5.948

Review 5.  Case Report: Bartonella quintana Endocarditis Outside of the Europe-African Gradient: Comprehensive Review of Cases within North America.

Authors:  John C Lam; Kevin Fonseca; Kanti Pabbaraju; Bonnie L Meatherall
Journal:  Am J Trop Med Hyg       Date:  2019-05       Impact factor: 2.345

6.  Detection of Bartonella quintana by direct immunofluorescence examination of blood smears of a patient with acute trench fever.

Authors:  C Foucault; J M Rolain; D Raoult; P Brouqui
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

7.  Hemin-binding proteins as potent markers for serological diagnosis of infections with Bartonella quintana.

Authors:  Mayumi Matsuoka; Toshinori Sasaki; Naomi Seki; Mutsuo Kobayashi; Kyoko Sawabe; Yuko Sasaki; Keigo Shibayama; Tsuguo Sasaki; Yoshichika Arakawa
Journal:  Clin Vaccine Immunol       Date:  2013-02-13

8.  Pericardial effusion in a homeless man due to Bartonella quintana.

Authors:  P Y Levy; P E Fournier; M Carta; D Raoult
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

9.  Prevalence of Bartonella clarridgeiae and Bartonella henselae in domestic cats from France and detection of the organisms in erythrocytes by immunofluorescence.

Authors:  Jean-Marc Rolain; Caroline Locatelli; Luc Chabanne; Bernard Davoust; Didier Raoult
Journal:  Clin Diagn Lab Immunol       Date:  2004-03

10.  Randomized open trial of gentamicin and doxycycline for eradication of Bartonella quintana from blood in patients with chronic bacteremia.

Authors:  C Foucault; D Raoult; P Brouqui
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.